Vascular protection in patients with diabetes admitted for vascular surgery in a Canadian tertiary care hospital: Pilot study

Canadian Journal of Hospital Pharmacy

Volumn 66, Issue 4, 2013, Pages 227-232

  Sunderland, Melanie ^a,b   De Jong, Mandy ^a   Bates, Duane ^a  

^a FOOTHILLS HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diabetes mellitus; Peripheral artery disease; Vascular protection

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CANADIAN; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PATIENT COUNSELING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PILOT STUDY; RETROSPECTIVE STUDY; SMOKING CESSATION; TERTIARY CARE CENTER; VASCULAR SURGERY; VERY ELDERLY;

EID: 84902172005     PISSN: 00084123     EISSN: 19202903     Source Type: Journal    
DOI: 10.4212/cjhp.v66i4.1270     Document Type: Article

References (16)

1. Peripheral artery disease-legs. In: A.D.A.M. medical encyclopedia [Internet]. Atlanta (GA): A.D.A.M. Inc; [last reviewed 2012 May 14; cited 2012 Aug 15]. Available from: www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001223/
2. Burns P, Lima E, Bradbury AW. Second best medical therapy. Eur J Vasc Endovasc Surg. 2002;24(5):400-4.
3. Hackam DG, Goodman SG, Anand SS. Management of risk in peripheral artery disease: recent therapeutic advances. Am Heart J. 2005; 150(1):35-40.
4. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Vascular protection for people with diabetes. In: Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32 Suppl 1:S102-6.
5. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Can J Cardiol. 2009;25(10):567-79.
6. Bell AD, Roussin A, Cartier R, Chan WS, Douketis JD, Gupta A, et al.; Canadian Cardiovascular Society. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol. 2011;27 Suppl A:S1-59.
7. Canadian Cardiovascular Society. Canadian guidelines for the management of peripheral arterial disease (PAD). Can J Cardiol. 2005;21(12): 997-1006.
8. Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45(4):645-54; discussion 653-4.
9. Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, et al.; HOPE study investigators. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J. 2004; 25(1):17-24.
10. Feldman DN, Moussa ID. Efficacy of aspirin for secondary prevention in patients with peripheral artery disease. Expert Rev Cardiovasc Ther. 2009;7(10):1203-7.
11. Bismuth J, Klitfod L, Sillesen H. The lack of cardiovascular risk factor management in patients with critical limb ischaemia. Eur J Vasc Endovasc Surg. 2001;21(2):143-6.
12. Khan S, Flather M, Mister R, Delahunty N, Fowkes G, Bradbury A, et al. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. Eur J Vasc Endovasc Surg. 2007;33(4):442-50.
13. Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral artery disease. Circulation. 2011;124(1):17-23.
14. Anand SS, Kundi A, Eikelboom J, Yusuf S. Low rates of preventive practices in patients with peripheral vascular disease. Can J Cardiol. 1999;15(11):1259-63.
15. Kundhal KK, Chin SL, Harrison L, Nowacki B, Doobay B, Titley J, et al. Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in Canada. Can J Cardiol. 2007;23(5):357-61.
16. Grindrod KA, Patel P, Martin JE. What interventions should pharmacists employ to impact health practitioners' prescribing practices? Ann Pharmacother. 2006;40(9):1546-57.